Hibridación in situ fluorescente: herramienta en el diagnóstico de las hemopatías malignas
Lavaut Sánchez, Kalia; Hernández Aguilar, Norbelys; Ruiz Moleón, Vera.
Rev. cuba. hematol. inmunol. hemoter
; 32(1): 99-109, ene.-mar. 2016. ilus, graf
Artigo em Espanhol | LILACS | ID: lil-794149
Documentos relacionados
Hibridación in situ fluorescente: herramienta en el diagnóstico de las hemopatías malignas
Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Aptamer-Based Multiparameter Analysis for Molecular Profiling of Hematological Malignancies.
[Reporte de la Primera Reunión Nacional de Consenso para la Inmunofenotipificación de Leucemias Agudas].
Advances in next-generation sequencing and emerging technologies for hematologic malignancies.
Microfluidic channel-assisted screening of hematopoietic malignancies.
Application of Multiplex Microfluidic Electrochemical Sensors in Monitoring Hematological Tumor Biomarkers.
[NGS-based multi-gene panel testing in hematological malignancies: germline variants and related issues].
Useful information provided by graphic displays of automated cell counter in hematological malignancies.
CAR-T cell therapy for patients with hematological malignancies. A systematic review.